| http://www.w3.org/ns/prov#value | - This study was a secondary aim of a randomized double-blind, placebo-controlled clinical trial (RCT) evaluating the effect of valacyclovir prophylaxis (500 mg twice daily versus placebo) on maternal HIV-1 RNA levels; the study design, methods and main findings have been published (http://clinicaltrials.gov NCT00530777) [10].
|
